Built by laboratorians,
for laboratorians

Howard is co-founder of Diagnostic Support Services and serves as the company's Chairman and Chief Executive Officer. Howard has dedicated his career to the healthcare industry and has spent more than 30 years building and leading medical laboratory and healthcare companies.

Prior to starting Diagnostic Support Services, Howard was a founding member of Progenity, a women's health genetics testing laboratory and biotechnology company focused on novel and innovative technologies. While at Progenity, Howard served on the board and led the company's operational functions.

Before that, Howard was a founder of Sequenom's Center for Molecular Medicine, a molecular diagnostics laboratory, where he led operations and created the company's first commercial capabilities. Howard started his career at Quest Diagnostics, where he spent almost 15 years in a variety of roles and positions.

Jared is a co-founder of Diagnostic Support Services and serves as the company's Chief Technology Officer. In addition to leading the technology strategy at Diagnostic Support Services, Jared also serves as a founder and partner for Gistia Healthcare, a technology development and healthcare data analytics company.

Prior to this, Jared worked for Progenity, a genetics laboratory and biotechnology company, as the organization's CIO.

Jared was also the founder of the Kearns Group, a technology consulting organization servicing the needs of healthcare, financial and automotive industries.

Chuck Wayland serves as Chief Commercial Officer at Diagnostic Support Services (DS2), where he leads sales, marketing, business development, customer success, and strategic growth initiatives. With more than 25 years of commercial leadership experience, Chuck has a proven track record of building high-performing teams, accelerating revenue growth, and expanding market presence across healthcare, diagnostics, and life sciences.

Prior to joining DS2, Chuck held senior commercial leadership positions at QIAGEN as Head of North American Sales, Progenity as Vice President of Sales, and Metabolon as Head of Global Sales. Throughout his career, he has developed and executed growth strategies, established strategic partnerships, and successfully scaled businesses. His experience includes leading commercial organizations with revenue responsibility approaching $500 million, driving growth across established global enterprises and emerging life sciences companies.

At DS2, Chuck is focused on expanding the company's market presence, strengthening strategic partnerships, and positioning DS2 as a leading integrated diagnostic operations partner.